Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 480

Results For "ABLE"

5837 News Found

Snowman Logistics expands its facility in Coimbatore
Supply Chain | February 21, 2022

Snowman Logistics expands its facility in Coimbatore

The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others


Sputnik Light gets a boost as China changes rules on boosters
News | February 21, 2022

Sputnik Light gets a boost as China changes rules on boosters

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters


Vestige launches Pre-Gluco Health capsules for the early prevention of diabetes
Healthcare | February 21, 2022

Vestige launches Pre-Gluco Health capsules for the early prevention of diabetes

According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Corbevax receives EUA for 12-18 age group
News | February 21, 2022

Corbevax receives EUA for 12-18 age group

It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19


Merck announces leadership team for human health business
People | February 20, 2022

Merck announces leadership team for human health business

In the interim, Deepak Khanna will lead Human Health International.


USFDA lifts clinical hold on submission of Covaxin
News | February 20, 2022

USFDA lifts clinical hold on submission of Covaxin

Covaxin is a whole-virion inactivated Covid-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades


Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022
News | February 19, 2022

Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector


Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'
News | February 19, 2022

Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'

Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).


Tremfya achieves greater clinical responses in patients with ulcerative colitis
Biotech | February 19, 2022

Tremfya achieves greater clinical responses in patients with ulcerative colitis

Data from the Phase 2b QUASAR Induction Study showed approximately 60% of patients achieved the primary endpoint of clinical response, and approximately 30% showed endoscopic improvement with TREMFYA treatment compared with placebo